Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D001058:Apomorphine / Q000037:antagonists & inhibitors; D002375:Catalepsy / Q000139:chemically induced; D004285:Dogs; D004952:Esters / Q000494:pharmacology; D005476:Fluphenazine / Q000494:pharmacology / Q000633:toxicity; D006168:Guinea Pigs; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010169:Palmitic Acids / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology / Q000633:toxicity; D010880:Piperidines / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D013045:Species Specificity; D013449:Sulfonamides / Q000378:metabolism / Q000633:toxicity; D013997:Time Factors; D014476:Undecylenic Acids / Q000494:pharmacology
D014150:Antipsychotic Agents; D004952:Esters; D010169:Palmitic Acids; D010640:Phenothiazines; D010880:Piperidines; D013449:Sulfonamides; D014476:Undecylenic Acids; D000661:Amphetamine; D001058:Apomorphine; D005476:Fluphenazine